Dr. Wendy King, faculty member of the EDC, has been recognized as a World Expert in Obesity for being among the top 0.1% of obesity researchers in the last decade based on peer-reviewed publications.
Hormone replacement therapy is a common treatment for menopause-related symptoms, and new research from the University of Pittsburgh Graduate School of Public Health reinforces the importance of tailoring hormone therapy to each patient, based on her individual risk factors for cardiovascular disease.
EDC Co-Director Dr. Maria Mori Brooks will lead the data coordinating center for a $19.2 million international NIH study that will evaluate treatments for sickle cell disease
The clinical trial will assess two treatment strategies for adults with sickle cell disease. In particular, the trial will assess the effectiveness of adding red blood cell exchange transfusion (or erythrocytapheresis) to standard of care medical therapy as compared with the standard of care.
“Bariatric surgery is the most effective treatment for severe obesity. It results in sustained weight reduction and remission of diabetes and other health problems in the majority of patients,” said lead author Wendy King, Ph.D., associate professor in Pitt Public Health’s Department of Epidemiology.
Dr. King, along with senior author EDC Co-Director Steven Belle, found that measuring the percentage of weight regained following the maximum amount of weight lost after bariatric surgery can help predict a patient’s risk of several serious health problems.
Dr. Gretchen White publishes article on Alcohol Disorder Screening Tests in Weight-Loss Surgery Patients
Dr. Gretchen White, along with EDC faculty member Dr. Wendy King, found that people who undergo Roux-en-Y gastric bypass surgery, a common type of bariatric surgery, are at increased risk for alcohol-related problems.